rhodopsin gene therapy (Baylor College of Medicine/Sangamo)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerhodopsin gene therapy (Baylor College of Medicine/Sangamo)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRhodopsin stimulants
TargetsRhodopsin
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSangamo Therapeutics IncBaylor College Of Medicine
Active IndicationsN/A
Inactive IndicationsRetinitis Pigmentosa

Other Information

ATC CodeN/A
Related LinksN/A